Focused on one of the most aggressive brain cancers, this market is advancing through liquid biopsies, molecular profiling, and AI-enhanced MRI imaging. Early and accurate detection remains the primary driver, with significant investment in biomarker research to improve patient outcomes. https://marketintelo.com/report/glioblastoma-diagnostics-market